Status:
COMPLETED
Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement
Lead Sponsor:
Hams Hamed Abdelrahman
Collaborating Sponsors:
Alexandria University
Conditions:
Furcation Defects
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graf...
Detailed Description
The study is a randomized, controlled clinical trial. Patients were randomly divided into two equal groups, Group I (Test group): included seven Grade II furcation defects treated by beta tricalcium p...
Eligibility Criteria
Inclusion
- • Presence of a lower molar with critical size grade II furcation defect (15) with a horizontal component of 4 mm and a vertical component of 4 to 6 mm (18), detected using Naber's probe and William's periodontal probe.
- Patient's age between 30 - 50 years.
- Both sexes.
- The patient should be psychologically accepting the procedures.
- Patients should be systemically free.
Exclusion
- • Uncooperative patients regarding oral hygiene measures performance.
- Patients with para functional habits.
- Smokers.
- Pregnant or lactating women.
- Patients who underwent any periodontal surgeries in the study site during the six months prior to study.
Key Trial Info
Start Date :
April 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04443972
Start Date
April 12 2018
End Date
February 4 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
outpatient clinic of oral medicine department, faculty of dentistry, Alexandria university
Alexandria, Egypt